Rosacea doesn't stop at the cheeks.
Your IPL shouldn't either.
The same broad-spectrum IPL you already use for facial rosacea — Sciton BBL, Lumenis, Cynosure, or similar — can extend up to the lid margin, where the same vascular disease lives and where your patients can already see it in the mirror. We bring the clinical supervision and carry the liability; you bring the chair, the room, and the patients already on your books.
The Opportunity
The rosacea on their face doesn't stop at their eyelids
Your patients come in for their cheeks, nose, and chin. But the same vascular disease — the redness they already see every morning — continues into their lid margins and periocular skin. Historically, that part of the face was off-limits in an aesthetic setting. With an optometrist on-site, it isn't anymore.
Up to 72%
of rosacea patients have ocular involvement
Red lid margins, telangiectasia along the lash line, chronic eye redness — already visible on the face.
16M
Americans with rosacea
A category as large as dry eye — and uniquely visible, which is why patients pay to fix it.
Same device
Your existing IPL, new surface
The broad-spectrum IPL you already own extends up to the lid margin. Zero new capex.
$500–$700
Median annual patient spend
Patients already budget this on drops and topicals that don’t hold. IPL beats the category.
Where the money is
A new revenue stream that shares your existing patient list
You already own the equipment. You already have the patients — every rosacea client on your books is a candidate, because up to 72% of them have ocular signs they've never had treated. There's zero customer acquisition cost, zero new capex, and no competing med spa in the Bay Area offering this today. The only thing standing between your current IPL chair and a second indication is the clinical supervision to do it safely — and that's what the partnership provides.
The clinical story (measurable dry eye and MGD relief) is real, but it's secondary. The primary reason patients book is what they see in the mirror: red, inflamed lid margins they can finally do something about — without leaving the brand and setting they already trust.
The Partnership
How it works
A turnkey extension of the IPL work you already do — not a franchise, not a sublease, not another box to install. Just a second indication on a device you already own, with the clinical supervision to deliver it.
1. Intake & triage
We handle rosacea + ocular screening, symptom intake, and clinical eligibility — fully online. Your front desk only sees patients who are ready to book.
2. On-site clinical oversight
A licensed Doctor of Optometry supervises every lid-margin session. Your aesthetic team keeps their role on the face; clinical responsibility for the eye area sits with us.
3. Use your existing chair
Your existing broad-spectrum IPL extends from facial rosacea up to the lid margin under OD supervision. Same device, same protocol family, same room. Zero new capex.
4. New revenue, same patient list
Transparent per-session revenue share. Zero customer acquisition cost — every existing rosacea client on your books is a candidate for the second indication.
What we bring
- • Doctor of Optometry supervision & liability
- • Treatment protocols & clinical workflows
- • Patient intake, triage, & scheduling
- • Staff training on clinical handoff
- • Compliance & documentation
- • Co-branded marketing materials
What you bring
- • Existing broad-spectrum IPL
- • Treatment room time during partnered hours
- • Your existing rosacea & IPL patient base
- • Front-desk support for scheduled visits
- • The brand and setting your patients already trust
Your Clinician
You're not partnering with a device
You're partnering with a doctor. Here's who's on the other side of the partnership — the same clinician who will be in your treatment room every session.
Partner Clinician
Dr. Aaron Motacek, O.D.
Founder, Optometry MedSpa
Licensure
Doctor of Optometry
California-licensed, in good standing
Years in practice
[XX years]
Clinical + periocular IPL work
Specialization
Dry eye & ocular surface
Meibomian gland disease, periocular IPL, rosacea-adjacent care
Continuing education
[Memberships / CE hours]
TFOS, AAO, dry-eye societies — [user to confirm]
Philosophy
[User to write a 2–3 sentence bio paragraph here. Suggested angle: why this work matters, what draws you to the rosacea-to-ocular-surface continuum specifically, and what med spa partners can expect from you as a collaborator — warm, specific, not boastful.]
Regulatory & Compliance
Clean lines of responsibility
Everything involving the eye, lid margin, or ocular surface lives on our side of the partnership — clinically, legally, and operationally. Your existing aesthetic scope stays intact, unchanged, and uncomplicated.
We carry the clinical compliance
- California Board of Optometry license in good standing
- Professional malpractice insurance in force ([carrier], [policy limit])
- HIPAA-covered entity — BAA template available for onboarding
- Off-label clinical judgment and liability sits with the OD
- Adverse-event protocol with an on-call OD during partner hours
- Clinical documentation: treatment logs, informed consent, progress notes
You keep operating on your existing scope
- Facial IPL work (cheeks, nose, chin) stays under your aesthetic scope — unchanged
- Your staff’s scope of practice is untouched — they don’t touch the lid margin
- No new liability landing on your team or your medical director
- No new insurance riders required — confirmed with your carrier during onboarding
- Your brand, your setting, your patient relationship — all remain yours
Carrier, policy limits, and specific coverage details are confirmed during the intro call — we'll walk through them together, document it in writing, and make sure your own counsel is comfortable before anything is signed.
How the Handoff Works
Three parties, one seamless visit
Every stage of a patient's care shows exactly who's involved and who's responsible. Solid dots mean the party is the lead at that step; faint dots mean they're present but not driving.
Stage 1
Intake quiz
Patient completes a short online symptom quiz. We triage eligibility before the first visit lands on your calendar.
PatientOptometry MedSpa• leadStage 2
Scheduling
Your front desk books the slot through our shared intake system. We confirm clinical fit in parallel.
Med Spa• leadOptometry MedSpaStage 3
Evaluation visit
Patient arrives at your med spa. OD performs the evaluation on-site, in your room, using your existing workflow.
PatientMed SpaOptometry MedSpa• leadStage 4
Treatment session
Patient in your IPL chair. OD operates the device at the lid margin under direct supervision.
PatientMed SpaOptometry MedSpa• leadStage 5
Aftercare
We send aftercare instructions and check in 48 hours later. No load on your team.
PatientOptometry MedSpa• leadStage 6
Follow-up visit
Patient returns to your med spa for reassessment and the next session in the series.
PatientMed SpaOptometry MedSpa• lead
Illustrative Economics
What does this look like?
A rough model of monthly revenue at illustrative pricing. Actual terms are set per partnership — these numbers assume a 50/50 revenue share and a 4-session IPL series at $400/session.
Monthly gross
$16,000
Your share / mo
$8,000
Your share / yr
$96,000
Illustrative only. Does not include aesthetic upsell revenue from patients who convert from dry-eye treatment into your existing service menu — which, based on national data, is typically 30–50% of treated patients within 12 months.
Why Now
The window is open
You're already treating facial rosacea on the cheeks, nose, and chin. But when a patient looks in the mirror, the redness at their lid margins and around their eyes is often the first thing they see — and historically, it's the one place IPL couldn't reach in an aesthetic setting, because treating the eyelid required optometric scope of practice.
Clinicians have been using IPL around the eyes for over a decade. The evidence base has consolidated — 13+ RCTs, multiple meta-analyses, 90%+ efficacy rates — and in 2021 the FDA issued the first dedicated clearance for dry eye disease (Lumenis OptiLight). The broader clinical literature spans both on-label OptiLight work and off-label use of other premium broad-spectrum IPLs, and yet in the Bay Area, zero med spas are offering any of it. The operators who partner with an OD first will own a complete rosacea-to-adnexa treatment arc in their neighborhood: one chair, one device, a deeper relationship with every rosacea patient already on their books, and a measurable secondary benefit for dry eye symptoms.
The treatment exists. The patients are already yours. What's missing is the clinical infrastructure to deliver it safely — and that's what we bring.
Operator FAQ
Questions we get asked
Let's talk
A 30-minute call to walk through your IPL setup, your existing rosacea patient list, and the revenue math for your specific volume. No pressure, no pitch deck — just a conversation between operators about whether this makes sense for your spa.